Your browser doesn't support javascript.
loading
Increased plasma amyloid beta protein 1-42 levels in Down syndrome.
Mehta, P D; Dalton, A J; Mehta, S P; Kim, K S; Sersen, E A; Wisniewski, H M.
Afiliação
  • Mehta PD; Department of Immunology, New York State Institute for Basic Research, Staten Island 10314-6399, USA. pdmehta@worldnet.att.net
Neurosci Lett ; 241(1): 13-6, 1998 Jan 23.
Article em En | MEDLINE | ID: mdl-9502204
ABSTRACT
Amyloid beta protein 1-40 (A beta40) and A beta42 levels were quantitated in plasma from 43 persons with Down syndrome (DS; 26-68 years of age), 43 age-matched normal controls, and 19 non-DS mentally retarded (MR) persons (26-91 years of age) by using a sandwich enzyme linked immunosorbent assay. A beta40 levels were higher in DS and MR than controls, but were similar between DS and MR groups. A beta42 levels were higher in DS than controls or MR persons. The ratios of A beta42/A beta40 were higher in DS than controls or MR persons. The findings are consistent with those seen in DS brains.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Síndrome de Down Idioma: En Ano de publicação: 1998 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Síndrome de Down Idioma: En Ano de publicação: 1998 Tipo de documento: Article